Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia

per Perrotti, Danilo, Neviani, Paolo
Publicat 2012

Targeting A Tumor Suppressor To Suppress Tumor Growth: News and Views on Protein Phosphatase 2A (PP2A) as a Target for Anti-cancer Therapy

per Perrotti, Danilo, Neviani, Paolo
Publicat 2013

SETting OP449 into the PP2A-Activating-Drug family

per Neviani, Paolo, Perrotti, Danilo
Publicat a Clin Cancer Res (2014)

A “RANning” leap with “XPOrt” into TKI resistance

per Rassool, Feyruz, Perrotti, Danilo
Publicat a Blood (2015)

BCR–ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention

per PERROTTI, DANILO, HARB, JASON G.
Publicat a Leuk Lymphoma (2011)

The new role of microRNAs in cancer

per Perrotti, Danilo, Eiring, Anna M
Publicat a Future Oncol (2010)

From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies

per Ciccone, Maria, Calin, George A., Perrotti, Danilo
Publicat a Front Oncol (2015)

Chronic myeloid leukemia: mechanisms of blastic transformation

per Perrotti, Danilo, Jamieson, Catriona, Goldman, John, Skorski, Tomasz
Publicat 2010

Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity

per Salomoni, Paolo, Perrotti, Danilo, Martinez, Robert, Franceschi, Claudio, Calabretta, Bruno
Publicat 1997

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay

per Perrotti, Danilo, Silvestri, Giovannino, Stramucci, Lorenzo, Yu, Justine, Trotta, Rossana
Publicat a Curr Drug Targets (2017)

Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo

per Skorski, Tomasz, Perrotti, Danilo, Nieborowska-Skorska, Malgorzata, Gryaznov, Sergei, Calabretta, Bruno
Publicat 1997

Chronic myeloid leukemia: the basis of treatment for tomorrow

per Carella, Angelo M., Goldman, John M., Martinelli, Giovanni, Melo, Junia V., Perrotti, Danilo
Publicat 2011

Blastic transformation of p53-deficient bone marrow cells by p210(bcr/abl) tyrosine kinase

per Skorski, Tomasz, Nieborowska-Skorska, Malgorzata, Wlodarski, Pawel, Perrotti, Danilo, Martinez, Robert, Wasik, Mariusz A., Calabretta, Bruno
Publicat 1996

Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis

per Iozzo, Renato V., Chakrani, Fatima, Perrotti, Danilo, McQuillan, David J., Skorski, Tomasz, Calabretta, Bruno, Eichstetter, Inge
Publicat 1999

CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities

per Lee, Young-Jin, Jones, Letetia C., Timchenko, Nikolai A., Perrotti, Danilo, Tenen, Daniel G., Kogan, Scott C.
Publicat 2006

BCR-ABL Prevents c-Jun-Mediated and Proteasome-Dependent FUS (TLS) Proteolysis through a Protein Kinase CβII-Dependent Pathway

per Perrotti, Danilo, Iervolino, Angela, Cesi, Vincenzo, Cirinná, Maria, Lombardini, Silvia, Grassilli, Emanuela, Bonatti, Silvia, Claudio, Pier Paolo, Calabretta, Bruno
Publicat 2000

hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis

per Iervolino, Angela, Santilli, Giorgia, Trotta, Rossana, Guerzoni, Clara, Cesi, Vincenzo, Bergamaschi, Anna, Gambacorti-Passerini, Carlo, Calabretta, Bruno, Perrotti, Danilo
Publicat 2002

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-activated Leukemias

per Muvarak, Nidal, Kelley, Shannon, Robert, Carine, Baer, Maria R., Perrotti, Danilo, Gambacorti-Passerini, Carlo, Civin, Curt, Scheibner, Kara, Rassool, Feyruz
Publicat a Mol Cancer Res (2015)

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

per Doshi, Kshama A., Trotta, Rossana, Natarajan, Karthika, Rassool, Feyruz V., Tron, Adriana E., Huszar, Dennis, Perrotti, Danilo, Baer, Maria R.
Publicat a Oncotarget (2016)

Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”

per Perrotti, Danilo, Agarwal, Anupriya, Lucas, Claire M., Narla, Goutham, Neviani, Paolo, Odero, Maria D., Ruvolo, Peter P., Verrills, Nicole M.
Publicat a Sci Transl Med (2019)